Axsome Therapeutics’ (AXSM) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. HC Wainwright currently has a $180.00 price target on the stock. A number of other equities research analysts have also recently commented on AXSM. Cantor Fitzgerald restated an overweight rating […]
More Stories
Trump Proposes Rebates for US Taxpayers From Tariff Revenues
By Andrew Moran President Donald Trump floated the idea of sending U.S. taxpayers rebate checks from tariff income collected this...
Bree Purganan: Jalen Green’s Mother, Nurse, and Philanthropist
You might know Jalen Green as a rising NBA star. But behind his success is Bree Purganan, his mother. She...
Choreo LLC Sells 6,043 Shares of CSX Corporation (NASDAQ:CSX)
Choreo LLC lowered its position in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 9.6% during the first quarter,...
Y Intercept Hong Kong Ltd Sells 61,771 Shares of Comcast Corporation (NASDAQ:CMCSA)
Y Intercept Hong Kong Ltd reduced its stake in Comcast Corporation (NASDAQ:CMCSA – Free Report) by 63.6% in the first...
Wednesday Season 3: Netflix renews Third Season
Netflix has officially said yes to Wednesday Season 3. They made the announcement even before Season 2 premieres. That’s rare,...
Is Sarah Hadland Married? Husband, Kids, and Relationship Status
Ever watched a British comedy and thought, “Wait, who’s that funny lady?” You might have just seen Sarah Hadland. She’s...